ATE321530T1 - Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure - Google Patents

Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure

Info

Publication number
ATE321530T1
ATE321530T1 AT02767353T AT02767353T ATE321530T1 AT E321530 T1 ATE321530 T1 AT E321530T1 AT 02767353 T AT02767353 T AT 02767353T AT 02767353 T AT02767353 T AT 02767353T AT E321530 T1 ATE321530 T1 AT E321530T1
Authority
AT
Austria
Prior art keywords
pharmaceutically acceptable
acceptable salt
composition containing
paroxetine
containing paroxetine
Prior art date
Application number
AT02767353T
Other languages
English (en)
Inventor
Causeret Nathalie C M Barges
Nicola L A Marzolini
Padma Meneaud
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0119467.9A external-priority patent/GB0119467D0/en
Priority claimed from GB0119468A external-priority patent/GB0119468D0/en
Priority claimed from GB0119469A external-priority patent/GB0119469D0/en
Priority claimed from GB0119470A external-priority patent/GB0119470D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE321530T1 publication Critical patent/ATE321530T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02767353T 2001-08-09 2002-08-09 Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure ATE321530T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0119467.9A GB0119467D0 (en) 2001-08-09 2001-08-09 Novel compound
GB0119468A GB0119468D0 (en) 2001-08-09 2001-08-09 Novel composition
GB0119469A GB0119469D0 (en) 2001-08-09 2001-08-09 Novel compositions
GB0119470A GB0119470D0 (en) 2001-08-09 2001-08-09 Novel composition

Publications (1)

Publication Number Publication Date
ATE321530T1 true ATE321530T1 (de) 2006-04-15

Family

ID=27447981

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02767353T ATE321530T1 (de) 2001-08-09 2002-08-09 Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure

Country Status (7)

Country Link
US (1) US20040242497A1 (de)
EP (1) EP1414408B1 (de)
JP (1) JP2005501066A (de)
AT (1) ATE321530T1 (de)
DE (1) DE60210308T2 (de)
ES (1) ES2261726T3 (de)
WO (1) WO2003013470A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100672184B1 (ko) 2004-09-21 2007-01-19 주식회사종근당 파록세틴의 콜린산 또는 콜린산 유도체 염
CN109568329A (zh) * 2018-12-07 2019-04-05 中国人民解放军第二军医大学 甘草酸及其药学上可接受的盐在制备抗抑郁药物中的应用
CN112137970A (zh) * 2019-06-28 2020-12-29 北京万全德众医药生物技术有限公司 一种盐酸帕罗西汀口腔崩解片及其制备工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
KR910011145A (ko) * 1989-12-14 1991-08-07 다니엘 에이. 스콜라 2세 향미를 오랫동안 지속적으로 방출하는 여러개의 캡슐로 싸여진 시스템을 갖는 압축된 당과류 정제
IT1274241B (it) * 1993-12-03 1997-07-15 Smithkline Beecham Farma Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
GB9402029D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Plc Novel formulation
CA2380449A1 (en) * 1999-08-17 2001-02-22 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
WO2002074238A2 (en) * 2001-02-16 2002-09-26 Lavipharm Laboratories Inc. Water soluble and palatable complexes

Also Published As

Publication number Publication date
EP1414408B1 (de) 2006-03-29
DE60210308T2 (de) 2006-11-30
JP2005501066A (ja) 2005-01-13
DE60210308D1 (de) 2006-05-18
EP1414408A1 (de) 2004-05-06
US20040242497A1 (en) 2004-12-02
WO2003013470A1 (en) 2003-02-20
ES2261726T3 (es) 2006-11-16

Similar Documents

Publication Publication Date Title
IS6002A (is) Pýrazólkarboxýlsýruafleiður, framleiðsla þeirra, lyfjasamsetningar sem innihalda þær
EE200200486A (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid
EP1201239A4 (de) Cyclische amine als ccr3 antagonisten
PL374325A1 (en) Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof
RS50360B (sr) Farmaceutske formulacije derivata platine
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
TR200003787A3 (tr) Kararli yavas salimli oral dozaj bilesimi.
IL157215A0 (en) Derivatives of n-(arylsulfonyl) beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing them
DK1417206T3 (da) Hidtil ukendte 2H-pyridazin-3-on-derivater, farmaceutiske præparater indeholdende det samme, og en fremgangsmåde til fremstilling af den aktive bestanddel
FI962418A (fi) Syklisiä amidijohdannaisia neurokiniini A antagonisteina
SE9900961D0 (sv) Novel compounds
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
IL157540A (en) Pharmaceutical compositions comprising n-(aryl)-2-arylethenesulfonamides, some such novel compounds and process for their preparation
SE0301699D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2003024933A1 (fr) Derive d'acide 2-phenyle-3-heteroarylpropionique ou son sel et medicaments le contenant
WO2004062562A3 (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
EA200501164A1 (ru) Индазоламиды с аналгетической активностью
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
ATE321530T1 (de) Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure
MY130373A (en) Linear basic compounds having nk-2 antagonist activity and formulations thereof
DE60302951D1 (de) Pyroglutaminsäure-salz von Amlodipin
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
DK1268522T3 (da) LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler
WO2003051276A3 (en) Therapeutic heterocycles

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties